Cedilla Therapeutics
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
245 1st St Ste 3, Cambridge, Massachuset...Phone Number
(929) 463-4100Website
www.cedillatx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company bringing a new dimension to precision oncology. Cedilla Therapeutics was founded in 2018 and based in Cambridge, Massachusetts.Explore more
Cedilla Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cedilla Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Cedilla Therapeutics
Product Launch: Get notified when Cedilla Therapeutics launches new products
Click to see if Cedilla Therapeutics had a recent Job posting/layoffs
Cedilla Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Cedilla Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Cedilla Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Cedilla Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Cedilla Therapeutics is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Cedilla Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Cedilla Therapeutics
Compare insights from companies similar to Cedilla Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cedilla Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cedilla Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cedilla Therapeutics.
Cedilla Therapeutics financials insights
Gather financial insights about Cedilla Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$56.2M
2019
Series A
$23.7M
2020
Series B
$57.6M
2021
Series B
$25M
Cedilla Therapeutics Tech Stack
A closer look at the technologies used by Cedilla Therapeutics
See more technologies
Most Recent Scoops
Funding
New Hire
Management Move
Sebastien Ronseaux has been named Director DMPK. Previously, Ronseaux served as Senior Scientist at Agios.
Funding
Left Company
Executive Move
Andrew Dawson, Chief Human Resources Officer, has left the organization.
Executive Moves, Personnel Moves, Left Company
Left Company
Executive Move
Executive Moves, Personnel Moves, Left Company
Cedilla Therapeutics News & Media
Cedilla Therapeutics to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cedilla Therapeutics announces that President & CEO Alexandra Glucksmann, Ph.D., will present at two upcoming investor conferences in February.Cedilla Therapeutics Expands Leadership Team with Key Appointments Across R&D And Finance
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cedilla Therapeutics, a biotechnology company bringing a new dimension to precision oncology, today announced appointments across its research and development (R&D) and finance teams, including Joshua Murtie, Ph.D., as Vice President of Biology and Chris Lindblom as Vice President of Finance. These hires are part of an ongoing initiative to expand Cedilla’s leadership and enable future growth as the company progresses its lead programs, conditional inhibitCedilla Therapeutics Completes $82.6M Series B Financing
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cedilla Therapeutics, a biotechnology company bringing a new dimension to precision oncology, today announced that it has raised an additional $25 million in an expansion of its Series B financing, bringing the total amount raised to $82.6 million. The oversubscribed Series B expansion includes new investors RA Capital Management, Janus Henderson Investors, Woodline Partners LP and Logos Capital, along with participation from existing investor Third Rock VentuCedilla Therapeutics Unveils Lead Programs for the Conditional Inhibition of TEAD and CDK2, Two High Value and Historically Undruggable Cancer Drivers
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cedilla Therapeutics, a biotechnology company bringing a new dimension to precision oncology, today revealed its two lead conditional inhibitor programs: an inhibitor of TEAD for the treatment of solid tumors, such as mesothelioma and certain squamous cell carcinomas; and a highly selective inhibitor of CDK2 for the treatment of multiple tumor types, including CDK4/6-resistant breast cancer, ovarian, uterine, stomach, and esophageal cancers. Both programs are
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cedilla Therapeutics
Sign Up For FreeTo access detailed company insights
Cedilla Therapeutics is a biotechnology company bringing a new dimension to precision oncology. Cedilla Therapeutics was founded in 2018 and based in Cambridge, Massachusetts.... Read More
